Yonhap Infomax NewsMay 20, 2025
FDA tightens COVID-19 vaccine approval process, requiring clinical trials for ages 6 months to 64 years, potentially increasing costs for pharmaceutical companies
#YonhapInfomax #FDA #COVID19Vaccines #ClinicalTrials #PharmaceuticalCompanies #VaccineApproval #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64062
FDA Tightens COVID-19 Vaccine Approval Standards - Clinical Trials Required

FDA tightens COVID-19 vaccine approval process, requiring clinical trials for ages 6 months to 64 years, potentially increasing costs for pharmaceutical companies

Yonhap Infomax